Tivic Health Systems Inc (TIVC) is a Healthcare · Medical Devices company listed on NASDAQ. Price $2.23 (+7.21%), Market cap $0.00B, 52-week low–high $0.74 ~ $4.45.
Valion Bio, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Financial statements, price targets, institutional (13F) holdings and related news for Tivic Health Systems Inc are updated in real time on BlackAll Trade.
Tivic Health Systems Inc trades at $2.23 (+7.21%). Real-time quotes and charts are available on BlackAll Trade.
Tivic Health Systems Inc has a market cap of about $0.00B.
Valion Bio, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The comp